Dexrazoxane: all 25 studies that test it
Page 1 of 1. Open to participants first (3), then studies with results posted, then the rest; newest registration first within each.
- The CARDIOPROTECT TrialRecruitingNCT07654426Phase 2
- Prevention of Anthracycline-Induced Cardiac Dysfunction With Dexrazoxane in Patients With Diffuse Large-B Cell LymphomaRecruitingNCT06220032Phase 3
- Dexrazoxane Hydrochloride in Preventing Heart-Related Side Effects of Chemotherapy in Participants With Blood CancersRecruitingNCT03589729Phase 2
- Prevention of Heart Failure Induced by Doxorubicin With Early Administration of DexrazoxaneCompletedNCT03930680Phase 1Results posted
- Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue SarcomaCompletedNCT02584309Phase 2Results posted
- A Phase I/II Study of KDX-0811(Dexrazoxane) in the Treatment of Accidental Extravasation of Anthracycline Anti-cancer AgentsCompletedNCT01596088Phase 1/2Results posted
- Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver CancerCompletedNCT00980460Phase 3Results posted
- Combination Chemotherapy and Dexrazoxane Followed by Surgery and Radiation Therapy in Treating Patients With Advanced Soft Tissue Sarcoma or Recurrent Bone SarcomaTerminatedNCT00544778Phase 2Results posted
- Chemotherapy Combined With Radiation Therapy for Newly Diagnosed CNS AT/RTCompletedNCT00084838Phase 2Results posted
- Dexrazoxane to Protect Against Hemorrhagic STEMICompletedNCT07502521Phase 2
- Use of the Cardioprotectant Dexrazoxane During Congenital Heart SurgeryStatus unknownNCT04997291Phase 1
- OlaReDo - Olaratumab and Rechallenge With Doxorubicin in Soft Tissue Sarcoma PatientsTerminatedNCT03698227Phase 2
- Use of the Cardioprotectant Dexrazoxane During Congenital Heart Surgery: Proposal for Pilot InvestigationTerminatedNCT02519335Phase 1
- Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified ChemotherapyActive, not recruitingNCT01871766Phase 2
- Study to Evaluate the Reduction of Cardiac Problems in Multiple Sclerosis Patients With Mitoxantrone and Dexrazoxane in CombinationStatus unknownNCT01627938Phase 2
- Dexrazoxane as a Protective Agent in Anthracycline Treated Breast CancerTerminatedNCT00955890Phase 2
- Obatoclax Mesylate, Vincristine Sulfate, Doxorubicin Hydrochloride, and Dexrazoxane Hydrochloride in Treating Young Patients With Relapsed or Refractory Solid Tumors, Lymphoma, or LeukemiaTerminatedNCT00933985Phase 1
- Dexrazoxane and Cisplatin in Treating Patients With Advanced Solid TumorsCompletedNCT00550901Phase 1
- A Clinical Trial on Topotect® (Dexrazoxane) in the Treatment of Accidental Extravasation of AnthracyclinesCompletedNCT00548704Phase 2/3
- Efficacy of TopotectTM (Dexrazoxane) for Accidental Extravasation of AnthracyclinesCompletedNCT00548561Phase 2/3
- Oblimersen Plus Combination Chemotherapy and Dexrazoxane in Treating Children and Adolescents With Relapsed or Refractory Solid TumorsCompletedNCT00039481Phase 1
- Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast CancerTerminatedNCT00016276Phase 3
- Combination Chemotherapy With or Without Dexrazoxane in Treating Children With Hodgkin's DiseaseCompletedNCT00005578Phase 3
- Combination Chemotherapy and Biological Therapy in Treating Patients With High-Risk Ewing's SarcomaCompletedNCT00003667Phase 2
- Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's DiseaseCompletedNCT00002827Phase 3